Overview
Mass spectrometry data analysis is the computational pipeline that converts raw spectral files from mass spectrometers into lists of identified and quantified peptides and proteins. Raw data undergo preprocessing steps, noise filtering, centroiding, charge state assignment, and peak picking, before peptide identification is attempted. The quality and depth of the final protein list depend critically on both the acquisition method and the computational strategy employed. Modern proteomics experiments routinely generate millions of spectra, making robust, automated analysis pipelines essential for extracting biological meaning from the data.
Methods
Database searching matches experimental tandem mass spectra against theoretical spectra generated in silico from a protein sequence database. Search engines such as SEQUEST, Andromeda, and Comet use cross-correlation or probability-based scoring to rank peptide-spectrum matches. De novo sequencing reconstructs peptide sequences directly from the spectrum without a database, which is valuable for organisms with unsequenced genomes or for identifying novel peptides. Hybrid approaches such as spectral library searching match against previously identified and validated spectra, offering higher sensitivity for known peptides. All methods require rigorous false discovery rate estimation, typically using target-decoy strategies.
Practical Protocol
A practical data analysis pipeline for label-free quantification begins with raw spectral files from a DDA acquisition. The first preprocessing step converts vendor-specific raw files to open formats such as mzML using ProteoWizard’s msConvert tool. Peak picking detects centroided peaks from profile-mode data by identifying local maxima and fitting the isotopic envelope. Noise filtering removes peaks below a signal-to-noise threshold of 2. Charge states are assigned by deconvolving isotopic patterns using algorithms such as Decon2LS. Retention time alignment is essential for cross-run quantification: the MaxLFQ algorithm aligns chromatograms by identifying common peptide features across runs and applying non-linear retention time shifts. After alignment, feature correspondences are established, the same peptide is tracked across all runs by matching its m/z, charge, and aligned retention time within windows of 10 ppm and 1 minute. Missing values, common in label-free experiments, are imputed using k-nearest neighbors imputation or left-censored imputation assuming missing values represent peptides below the detection limit. The final matrix of peptide intensities across samples is normalized using variance-stabilizing normalization and subjected to statistical testing such as limma or t-tests with multiple testing correction. A real-world example: this pipeline was applied to analyze the proteome of 200 cerebrospinal fluid samples from Alzheimer’s disease patients, identifying 50 consistently dysregulated proteins including tau fragments and amyloid-beta peptides. The same approach is used in plasma proteomics to discover candidate biomarkers for early detection of ovarian cancer across large patient cohorts.
Applications
Mass spectrometry data analysis is fundamental to every proteomics experiment. It supports the identification of proteins separated by SDS-PAGE, capillary zone electrophoresis, or HPLC, and is the computational engine behind modern proteomics and mass spectrometry workflows. Clinical proteomics relies on these analytical pipelines to discover biomarker candidates, while mass spectrometry instrumentation advances continue to drive the development of new algorithms for faster, more accurate data interpretation.
